189 related articles for article (PubMed ID: 17272741)
21. Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases.
Saibeni S; Bottasso B; Spina L; Bajetta M; Danese S; Gasbarrini A; de Franchis R; Vecchi M
Am J Gastroenterol; 2004 Oct; 99(10):1966-70. PubMed ID: 15447757
[TBL] [Abstract][Full Text] [Related]
22. Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles.
Boffa MB; Koschinsky ML
Clin Biochem; 2007 Apr; 40(7):431-42. PubMed ID: 17331488
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the role of thrombin activatable fibrinolysis inhibitor in retinal vein occlusion.
Gumus K; Kadayifcilar S; Eldem B; Ozcebe O
Retina; 2007 Jun; 27(5):578-83. PubMed ID: 17558319
[TBL] [Abstract][Full Text] [Related]
24. Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke.
Marciante KD; Totah RA; Heckbert SR; Smith NL; Lemaitre RN; Lumley T; Rice KM; Hindorff LA; Bis JC; Hartman B; Psaty BM
Pharmacogenet Genomics; 2008 Jun; 18(6):535-43. PubMed ID: 18496133
[TBL] [Abstract][Full Text] [Related]
25. Variation in fibrinogen FGG and FGA genes and risk of stroke: the Rotterdam Study.
Cheung EY; Bos MJ; Leebeek FW; Koudstaal PJ; Hofman A; de Maat MP; Breteler MM
Thromb Haemost; 2008 Aug; 100(2):308-13. PubMed ID: 18690352
[TBL] [Abstract][Full Text] [Related]
26. Phosphodiesterase 4D (PDE4D) gene variants and the risk of ischemic stroke in a South Indian population.
Munshi A; Babu MS; Kaul S; Shafi G; Anila AN; Alladi S; Jyothy A
J Neurol Sci; 2009 Oct; 285(1-2):142-5. PubMed ID: 19608201
[TBL] [Abstract][Full Text] [Related]
27. A case control study between diabetic and non-diabetic subjects with ischemic stroke.
Pinto A; Tuttolomondo A; Di Raimondo D; Di Sciacca R; Fernandez P; Di Gati M; Arnao V; Licata G
Int Angiol; 2007 Mar; 26(1):26-32. PubMed ID: 17353885
[TBL] [Abstract][Full Text] [Related]
28. Fibrinolytic inhibitor levels and polymorphisms in Behçet disease and their association with thrombosis.
Ricart JM; Ramón LA; Vayá A; España F; Santaolaria ML; Todolí J; Castelló R; Fontcuberta J; Estellés A
Br J Haematol; 2008 May; 141(5):716-9. PubMed ID: 18341631
[TBL] [Abstract][Full Text] [Related]
29. A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor.
Stanne TM; Olsson M; Lorentzen E; Pedersen A; Gummesson A; Gils A; Jood K; Engström G; Melander O; Declerck PJ; Jern C
Thromb Haemost; 2018 Feb; 118(2):298-308. PubMed ID: 29378355
[TBL] [Abstract][Full Text] [Related]
30. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.
Koutroubakis IE; Sfiridaki A; Tsiolakidou G; Coucoutsi C; Theodoropoulou A; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):912-6. PubMed ID: 18794606
[TBL] [Abstract][Full Text] [Related]
31. Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level.
Santamaría A; Martínez-Rubio A; Borrell M; Mateo J; Ortín R; Fontcuberta J
Haematologica; 2004 Jul; 89(7):880-1. PubMed ID: 15257950
[TBL] [Abstract][Full Text] [Related]
32. +1040 C/T polymorphism in coding region of thrombin-activatable fibrinolysis inhibitor gene and the risk of idiopathic recurrent fetal loss.
Pruner I; Djordjevic V; Miljic P; Kovac M; Antonijevic N; Rakicevic L; Radojkovic D
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):679-82. PubMed ID: 20729722
[TBL] [Abstract][Full Text] [Related]
33. Genetic variants on chromosome 9p21 and ischemic stroke in Chinese.
Hu WL; Li SJ; Liu DT; Wang Y; Niu SQ; Yang XC; Zhang Q; Yu SZ; Jin L; Wang XF
Brain Res Bull; 2009 Aug; 79(6):431-5. PubMed ID: 19559344
[TBL] [Abstract][Full Text] [Related]
34. Single-nucleotide polymorphisms of MMP-2 gene in stroke subtypes.
Fatar M; Stroick M; Steffens M; Senn E; Reuter B; Bukow S; Griebe M; Alonso A; Lichtner P; Bugert P; Meitinger T; Wienker TF; Hennerici MG
Cerebrovasc Dis; 2008; 26(2):113-9. PubMed ID: 18560213
[TBL] [Abstract][Full Text] [Related]
35. TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction.
Akatsu H; Yamagata H; Chen Y; Miki T; Kamino K; Takeda M; Campbell W; Kondo I; Kosaka K; Yamamoto T; Okada H
Br J Haematol; 2004 Nov; 127(4):440-7. PubMed ID: 15521922
[TBL] [Abstract][Full Text] [Related]
36. Diabetic and non-diabetic subjects with ischemic stroke: differences, subtype distribution and outcome.
Tuttolomondo A; Pinto A; Salemi G; Di Raimondo D; Di Sciacca R; Fernandez P; Ragonese P; Savettieri G; Licata G
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):152-7. PubMed ID: 17702553
[TBL] [Abstract][Full Text] [Related]
37. Klotho is a genetic risk factor for ischemic stroke caused by cardioembolism in Korean females.
Kim Y; Kim JH; Nam YJ; Kong M; Kim YJ; Yu KH; Lee BC; Lee C
Neurosci Lett; 2006 Oct; 407(3):189-94. PubMed ID: 16973281
[TBL] [Abstract][Full Text] [Related]
38. Association of specific haplotypes of GAS6 gene with stroke.
Muñoz X; Obach V; Hurtado B; de Frutos PG; Chamorro A; Sala N
Thromb Haemost; 2007 Aug; 98(2):406-12. PubMed ID: 17721624
[TBL] [Abstract][Full Text] [Related]
39. Risk of ischemic stroke associated with functional thrombin-activatable fibrinolysis inhibitor plasma levels.
Santamaría A; Oliver A; Borrell M; Mateo J; Belvis R; Martí-Fábregas J; Ortín R; Tirado I; Souto JC; Fontcuberta J
Stroke; 2003 Oct; 34(10):2387-91. PubMed ID: 12947154
[TBL] [Abstract][Full Text] [Related]
40. Association between genotype and plasma levels of thrombin-activated fibrinolysis inhibitor (TAFI) in the development of preeclampsia.
Acosta-Tejeda M; Baptista-González H; Rosenfeld-Mann F; Trueba-Gómez R; García-Latorre E
Thromb Res; 2011 Oct; 128(4):e39-42. PubMed ID: 21708401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
